Health & Medicine

Episode 1150: Ortho Surgeons Are Going to Read This Study Different Than Pharmacists

29 sec read2 views0 listens

A recent multicenter trial found that aspirin alone is non-inferior to rivaroxaban followed by aspirin for preventing venous thromboembolism after total knee or hip arthroplasty. This finding is significant for healthcare developers as it suggests a potential shift in post-operative thromboprophylaxis strategies, impacting pharmaceutical development and clinical decision-support tools. Orthopedic surgeons, particularly focused on bleeding risks, may favor the aspirin-only approach, influencing future treatment protocols and drug utilization.

Read the full article at Blog Archives - Pharmacy Joe

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Matt Damon Almost Starred as Robin in Two Different Batman Movies

A study comparing rivaroxaban followed by aspirin versus aspirin alone for thromboprophylaxis after total knee or hip arthroplasty found no significant difference in preventing venous thromboembolism or in bleeding events. This suggests aspirin alone...

Ali Nemati

Cybersecurity17 hours ago26 sec read

U.S. teen withdraws lawsuit against Meta over social media addiction

A U.S. teenager has withdrawn his lawsuit against Meta, ending a high-profile case examining the mental health impacts of social media on children before it went to trial. This decision follows recent settlements and legal actions against Meta over c...

Ali Nemati

Biotech & Pharma21 hours ago26 sec read

Transcripta Bio Raises $24M for AI-Driven Neurological Disease Therapies

Transcripta Bio, an AI-driven drug discovery startup, has raised $24 million to advance its neurological disease therapies. The funding will support clinical preparations for conditions like autism spectrum disorder and muscular dystrophy, leveraging...

Ali Nemati

Health & Medicine1 day ago28 sec read

STAT+: Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more

President Trump plans to impose escalating tariffs on imported generic medicines, starting at 100% in August 2028 and rising to 200% a year later. This move aims to encourage pharmaceutical manufacturing within the U.S., but it has drawn criticism fr...

Ali Nemati

Fitness & Wellness2 days ago28 sec read

FDA Issues Warning Letter Over APAPs

The FDA has issued a warning letter to BMC Medical concerning unapproved modifications to APAP devices and a failure to report a firmware correction for unexpected shutdowns. This is a critical alert for manufacturers and developers in the medical de...

Ali Nemati

Episode 1150: Ortho Surgeons Are Going to Read This Study Different Than Pharmacists

Related Articles

Matt Damon Almost Starred as Robin in Two Different Batman Movies

U.S. teen withdraws lawsuit against Meta over social media addiction

Transcripta Bio Raises $24M for AI-Driven Neurological Disease Therapies

STAT+: Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more

FDA Issues Warning Letter Over APAPs